Oxindole Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents

The initial reports on the use of oxindoles (2H-indol-2-ones) as kinase inhibitors were published by Japanese researchers at Kanegafuchi in the late 1980s as a small subset within a series of patent applications on 4-hydroxycinnamamidebased derivatives.